Mylan Inc Under Pressure As Epipen Prices Skyrocket

You know its bad when even Martin Shkreli is accusing you of price gauging for needed medical goods. The pharma bro who jacked up the price of a drug 5,000 percent overnight and planned other mass drug hikes at Kalobios before he was removed, has called out Mylan Inc. (NASDAQ:MYL) for jacking up the price of Epipen. Shkreli told NBC:

“Amazing that Epipen prices in CA & EU with prescription are about $85,” said one of the many consumers who were immediately on the Internet to register their disgust at Mylan. “No (government) negotiated buy in US.” Another accused the company of “forcing many families to gamble with their children’s lives.”

This could be a bit hypocritical but that...